A Phase 1 Study of AGEN2373, an Anti-CD137 Monoclonal Antibody, as Monotherapy and in Combination with AGEN1181, an Fc-Engineered Anti-CTLA-4 Monoclonal Antibody, in Patients with Advanced Cancer

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

CTRC Inpatient
University of Colorado Hospital

Study ID

Protocol Number: 22-0326

More information available at ClinicalTrials.gov: NCT04121676

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers